Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.
about
Outcomes of Active Surveillance for Clinically Localized Prostate Cancer in the Prospective, Multi-Institutional Canary PASS Cohort.Research Needs for Understanding the Biology of Overdiagnosis in Cancer Screening.A multiplex assay to measure RNA transcripts of prostate cancer in urine.Active surveillance in men with low-risk prostate cancer: current and future challenges.Outcomes of active surveillance for men with intermediate-risk prostate cancer.Precision Medicine in Active Surveillance for Prostate Cancer: Development of the Canary-Early Detection Research Network Active Surveillance Biopsy Risk CalculatorPIVOT and the challenges of localized prostate cancer care.Role of active surveillance in the management of localized prostate cancer.Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer.Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study.Divorcing diagnosis from treatment: contemporary management of low-risk prostate cancer.Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics.The dilemma of prostate-specific antigen testingModeling grade progression in an active surveillance study.A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant)A diagnosis of prostate cancer and pursuit of active surveillance is not followed by weight loss: potential for a teachable moment.Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies.Managing localized prostate cancer in the era of prostate-specific antigen screening.Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort.Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study.Factors influencing disease progression of prostate cancer under active surveillance: a McGill University Health Center cohort.Active surveillance: a review of risk-based, dynamic monitoring.
P2860
Q27308897-3ADC20B6-2707-4765-B8D0-221198511735Q30252065-2E5A6A63-B8A1-4E11-A9A5-27EC89C5F9C3Q34429720-C27ACB5E-92E2-4194-A8E5-5828E343C3ADQ34448113-DD243CE6-3ECD-4844-9A9F-B6EECC69DF07Q34679207-1A1B002B-B6CA-4923-BF2F-4C979D169BC8Q36093723-1AB54943-B321-4409-95C7-C9BDA9A0A93EQ36450800-C306C94B-9ADD-4243-B499-458F9A2EC947Q36520452-3B579EE8-1264-408E-92E0-3DCE62C6931DQ36892392-83E27E12-FA3F-41DC-AB3C-ECAB39DB47EDQ36907574-CE2640E2-E86F-492E-A441-A6D42FDC8908Q37025434-8A2114C2-E70A-48B7-A876-4C4F38B75CD2Q37037804-FB30A36D-E208-406D-8124-4533A23FCC53Q37252150-022AC817-CC03-4B28-9EB0-7CA4F2B6563EQ37638830-9DF2CA7A-EAC1-459B-9285-BC1926C8A983Q38066715-FEF94423-21FF-4C7C-B824-0986A903B731Q38804659-4132A47F-8A30-49EA-9486-146C5ACA5AE7Q39587790-91D7DCEC-D32D-40AD-AE3B-000FDFDDAEE0Q40772764-D325029B-DB04-434D-9CC8-7F602CB2BA2FQ42770558-0D6BB795-80EB-4EA1-A1C8-9CAC8F058F74Q42845103-17AD6755-27E8-4354-A814-319A018A8D03Q45046421-176E807C-3B1D-4045-B130-5C6B8F3FCFDAQ50703882-9D2AF28B-ABFB-42FE-8F4C-C387FD610252Q55265467-8ED61464-6846-4789-9C70-37370CE30325
P2860
Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@en
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@nl
type
label
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@en
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@nl
prefLabel
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@en
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@nl
P2093
P2860
P1433
P1476
Canary Prostate Active Surveil ...... ance cohort and biorepository.
@en
P2093
Daniel W Lin
Ian M Thompson
James D Brooks
Lisa F Newcomb
Martin E Gleave
Peter R Carroll
Peter S Nelson
Ziding Feng
P2860
P304
P356
10.1016/J.UROLOGY.2009.05.050
P407
P577
2009-09-16T00:00:00Z